JP2023502318A5 - - Google Patents
Info
- Publication number
- JP2023502318A5 JP2023502318A5 JP2022521601A JP2022521601A JP2023502318A5 JP 2023502318 A5 JP2023502318 A5 JP 2023502318A5 JP 2022521601 A JP2022521601 A JP 2022521601A JP 2022521601 A JP2022521601 A JP 2022521601A JP 2023502318 A5 JP2023502318 A5 JP 2023502318A5
- Authority
- JP
- Japan
- Prior art keywords
- seq
- spib
- irf8
- vector
- cells
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Granted
Links
Applications Claiming Priority (5)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| PT115833 | 2019-10-10 | ||
| PT11583319 | 2019-10-10 | ||
| EP20151310.8 | 2020-01-10 | ||
| EP20151310 | 2020-01-10 | ||
| PCT/EP2020/078429 WO2021069672A1 (en) | 2019-10-10 | 2020-10-09 | Composition for reprogramming cells into plasmacytoid dendritic cells or interferon type i-producing cells, methods and uses thereof |
Publications (3)
| Publication Number | Publication Date |
|---|---|
| JP2023502318A JP2023502318A (ja) | 2023-01-24 |
| JP2023502318A5 true JP2023502318A5 (https=) | 2023-10-17 |
| JP7728755B2 JP7728755B2 (ja) | 2025-08-25 |
Family
ID=72811870
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| JP2022521601A Active JP7728755B2 (ja) | 2019-10-10 | 2020-10-09 | 細胞を再プログラム化して形質細胞様樹状細胞またはｉ型インターフェロン産生細胞に変換する組成物、その方法および用途 |
Country Status (8)
| Country | Link |
|---|---|
| US (1) | US12600947B2 (https=) |
| EP (1) | EP4041869A1 (https=) |
| JP (1) | JP7728755B2 (https=) |
| KR (1) | KR20220077916A (https=) |
| CN (1) | CN114729322A (https=) |
| CA (1) | CA3153052A1 (https=) |
| IL (1) | IL292004B2 (https=) |
| WO (1) | WO2021069672A1 (https=) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| KR20220105161A (ko) * | 2019-11-25 | 2022-07-26 | 아스가르드 테라퓨틱스 아베 | 항원 제시를 위해 세포를 2형 수지상 세포 성분으로 재프로그래밍하기 위한 조성물, 그 방법 및 용도 |
| CA3223254A1 (en) * | 2021-07-02 | 2023-01-05 | Anders LAUSTSEN | Cgmp compliant production and expansion of plasmacytoid dendritic cells from hematopoietic stem and progenitor cells |
| WO2023176806A1 (ja) * | 2022-03-18 | 2023-09-21 | 国立研究開発法人産業技術総合研究所 | 線維芽細胞または線維芽細胞様細胞を従来型２型樹状細胞にリプログラミングするための方法 |
| WO2025198857A1 (en) * | 2024-03-20 | 2025-09-25 | The Regents Of The University Of California | Irf8-mediated reprogramming of the immune microenvironment in glioblastoma |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US20120208861A1 (en) * | 2008-08-28 | 2012-08-16 | Riken | Ifn type-i production inhibitor and method for screening for same |
| CA2785832A1 (en) * | 2010-01-04 | 2011-07-07 | Curna, Inc. | Treatment of interferon regulatory factor 8 (irf8) related diseases by inhibition of natural antisense transcript to irf8 |
| US8802438B2 (en) | 2010-04-16 | 2014-08-12 | Children's Medical Center Corporation | Compositions, kits, and methods for making induced pluripotent stem cells using synthetic modified RNAs |
| WO2012019168A2 (en) | 2010-08-06 | 2012-02-09 | Moderna Therapeutics, Inc. | Engineered nucleic acids and methods of use thereof |
| AU2012236099A1 (en) | 2011-03-31 | 2013-10-03 | Moderna Therapeutics, Inc. | Delivery and formulation of engineered nucleic acids |
| WO2018136551A1 (en) * | 2017-01-17 | 2018-07-26 | Tufts Medical Center, Inc. | Adoptive transfer of plasmacytoid dendritic cells to prevent or treat ocular diseases and conditions |
| EP3385373A1 (en) * | 2017-04-05 | 2018-10-10 | Centro de Neurociências e Biologia Celular | Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods and uses thereof |
| WO2018185709A1 (en) * | 2017-04-05 | 2018-10-11 | Centro De Neurociencias E Biologia Celular | Compositions for reprogramming cells into dendritic cells or antigen presenting cells, methods and uses thereof |
-
2020
- 2020-10-09 KR KR1020227013673A patent/KR20220077916A/ko active Pending
- 2020-10-09 JP JP2022521601A patent/JP7728755B2/ja active Active
- 2020-10-09 WO PCT/EP2020/078429 patent/WO2021069672A1/en not_active Ceased
- 2020-10-09 CN CN202080080049.6A patent/CN114729322A/zh active Pending
- 2020-10-09 US US17/766,369 patent/US12600947B2/en active Active
- 2020-10-09 EP EP20789106.0A patent/EP4041869A1/en active Pending
- 2020-10-09 CA CA3153052A patent/CA3153052A1/en active Pending
-
2022
- 2022-04-06 IL IL292004A patent/IL292004B2/en unknown
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| JP2023502318A5 (https=) | ||
| Tusup et al. | Design of in vitro transcribed mRNA vectors for research and therapy | |
| EP2669381A1 (en) | Method for expression of heterologous proteins using a recombinant negative-strand RNA virus vector comprising a mutated P protein | |
| JP2023506707A5 (https=) | ||
| CA2410948A1 (en) | Method for the purification of alphavirus replicon particles | |
| CN114729320B (zh) | 用于将细胞重新程序化为能够呈递抗原的树突细胞2型的组合物、方法及其用途 | |
| KR19980071443A (ko) | 구조 유전자의 세포 주기 조절된 발현을 위한 핵산 작제물 | |
| JP7728755B2 (ja) | 細胞を再プログラム化して形質細胞様樹状細胞またはｉ型インターフェロン産生細胞に変換する組成物、その方法および用途 | |
| CN114934070B (zh) | 间充质干细胞及其抗炎应用 | |
| JP7050696B2 (ja) | 核酸を細胞に導入するための方法 | |
| US20190136200A1 (en) | Cellular Reprogramming Utilizing mRNA | |
| JP7743980B2 (ja) | ヒトＴ細胞由来ｉＰＳ細胞由来の細胞傷害性Ｔ細胞 | |
| RU2006145306A (ru) | Аденовирусный/альфавитный гибридный вектор для эффективного введения и экспрессии терапевтических генов в опухолевые клетки | |
| CN101368180A (zh) | 一类能将间充质干细胞分化为造血细胞的小rna分子及其作用靶点 | |
| WO2019241569A1 (en) | Reprogramming cells with synthetic messenger rna | |
| JP2024154083A (ja) | ＳＡＲＳ－ＣｏＶ－２特異的細胞傷害性Ｔリンパ球のＴ細胞受容体又はその機能的断片 | |
| WO2019062887A1 (zh) | 一种体外产生环状核酸分子的方法 | |
| US20210196763A1 (en) | Reprogramming Cells With Synthetic Messenger RNA | |
| CN114941012B (zh) | 重组间充质干细胞及其应用 | |
| RU2850678C2 (ru) | Химерный белок, обладающий цитокиновой активностью интерлейкина 12, кодирующая его нуклеиновая кислота и плазмидный вектор для экспрессии в клетках млекопитающих | |
| WO2025144762A1 (en) | Reprogrammed cell modulation of cancer microenvironment by tumor homing personalized regenerative cells | |
| CN111471646B (zh) | 利用非抗生素筛选的游离型质粒载体制备iPSC的方法 | |
| CN120796257A (zh) | 一种可增强mRNA表达的5’UTR及其应用 | |
| CN108148860A (zh) | 含CpG-ODN基序重组抑制素质粒的构建方法及其应用 | |
| RU2495127C2 (ru) | РЕКОМБИНАНТНАЯ ПЛАЗМИДА pAd-SM, КОДИРУЮЩАЯ БЕЛКИ SOX2 И C-MYC ЧЕЛОВЕКА, ЯВЛЯЮЩАЯСЯ ОСНОВОЙ ДЛЯ ПОЛУЧЕНИЯ ВИРУЛЕНТНЫХ АДЕНОВИРУСОВ, ПРЕДНАЗНАЧЕННЫХ ДЛЯ ПОЛУЧЕНИЯ ИНДУЦИРОВАННЫХ ПЛЮРИПОТЕНТНЫХ КЛЕТОК ЧЕЛОВЕКА |